The Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of Kyleena 19.5 mg contraceptive systems. The firm fixed-price contract has a ceiling value of $5,718.30 and a period of performance through May 29, 2024. This award is part of a larger indefinite delivery contract (IDC) vehicle under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group specializes in providing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to federal agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA).
Generated 8/6/24, 11:10 AM